Member Info for greggreen

If you click youtube and go to their site, subtitles is translating (select settings).

Yeah he still looks shaken.

I wouldn't want to be taking a bet against Faron at the moment, very unpredictable.

Yeah fair enough, hopefully we are back to discussing again ^^. Wish you the best.

If you don't see de-rampers, then I understand your position. Not much ramping going on atm. Good luck finding a forum where investors are not speculating, because they are enthusiastic about their investment :D.

Forum rampers gave up, derampers giving it a good go ... 90% of the share trade is in Helsinki.

Nas is waking up, not seen this much trade since the end August.

Still fully loaded, can't add more. I'll stick with the way I started this year, hoping to be up before xmas, probably hold till 10 months into trial (unless something amazing happens). Too many unknowns to be betting against it that's for sure, unless you are into blackjack ;).

I remember Markku being fairly angry about goal posts being moved, which I suspect was investment. Timescales were stuck too. in my mind, a bit of funding may have shaved off some delay. Still had to get that phase 2 / 3 going to get to sales. You have to be careful with CEO banter vs RNS. It's part of their job to get you to buy and hold, of cause last few years I did. Missed a few juicy falls :D.

"H2 is the time for business", is good enough for me. To be fair most statements on the timeline have come to pass. Never minded raising for greater gain, so not particularly concerned. But maybe, just maybe, unseen opportunities will be so large we'll have to have a partner :D.

Great stuff, interview time ^^.

FDA update is always welcome! Last year we got H1 2024 webcast, so we should get a solid view on progress on/around the 27th I think at least. 2nd half of 2025 is looking busy pipeline wise. Traders were enjoying some spicy volatility. Dropping news flow has certainly calmed volatility, deliberate or not.

Did it work for AVCT?

I find it highly ironic to tell a poster to be patient, when they've been posting on the board since 2018 :D.

The timing could not be better for the FDA meeting, wow. Can't see Faron selling for 2Bn if Juho hopes for 1Bn a year in sales just for MDS alone, years down the road. Might finally push through a Partner deal, there's so many phase 3 trials to get going.

There is a half year financial report 27th August in the investors calendar for Jan to Jun 2025.

https://faron.com/investors/investor-relations/investor-calendar/

Focus is completely on Doctors and FDA. Not knowing the FDA application date, is probably making a the price a little more robust. There is still a good chunk of shorter term trading going on, so it will naturally drain. Optimistically hoping to be higher end of year with unexpected events, too the more realist 1 year after the phase 3 starts, for some solid results.

This is why I think the placebo although a gold standard, is not what I would want to hear, when already rolling a 5-6month life expectancy dice.

Guess it was worth more than a punt :D.

Its because it is a press release, not an RNS. I think Faron has clocked the importance of hammering home the impact of Bex from media too Doctors / Organizations in the field ... it may seem pointless to some Investors, but this is all for the FDA review imo. Hoping the trials will have wider access in some form. It is a bit chicken and egg, depending on the option this maybe become viable for the Partner to jump in (a larger study). If not maybe waiting a little while, I do not mind as long as it pulls through :D. Probably not worth thinking about what max value could be, too many factors, timescales, will power to hold on, finance. It passes the time I guess.

Stick CC on for subtitles. Use gear icon, then auto translate (English).